PULMATRIX, INC. Increase (Decrease) in Accounts Receivable
PULMATRIX, INC. (PULM) reported Increase (Decrease) in Accounts Receivable of $16.00 thousand for the 3-month period ending 2025-03-31, per its S-4/A filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-17
- PULMATRIX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $16.00K.
- PULMATRIX, INC. increase (decrease) in accounts receivable for the quarter ending 2024-12-31 was -$23.00K, a 126.44% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in accounts receivable for the quarter ending 2024-09-30 was -$612.00K, a 244.68% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in accounts receivable for the quarter ending 2024-06-30 was $65.00K.
- PULMATRIX, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$370.00K, a 130.06% decline from fiscal 2022.
- PULMATRIX, INC. increase (decrease) in accounts receivable for fiscal 2022 was $1.23M.
- PULMATRIX, INC. increase (decrease) in accounts receivable for fiscal 2021 was -$17.00K.
- PULMATRIX, INC. increase (decrease) in accounts receivable for fiscal 2020 was -$7.12M, a 198.83% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-03-31 | $16.00K S-4/A · filed 2026-08-03 | -$7.00K derived: sum of 2 quarters · filed 2026-09-17 | -$619.00K derived: sum of 3 quarters · filed 2026-09-17 | -$554.00K derived: sum of 4 quarters · filed 2026-09-17 |
| 2024-12-31 | -$23.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | -$635.00K derived: sum of 2 quarters · filed 2026-09-17 | -$570.00K derived: sum of 3 quarters · filed 2026-09-17 | -$928.00K S-4/A · filed 2026-09-17 |
| 2024-09-30 | -$612.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-16 | -$547.00K derived: sum of 2 quarters · filed 2025-10-16 | -$905.00K 10-Q · filed 2025-10-16 | -$818.00K derived: sum of 4 quarters · filed 2025-10-16 |
| 2024-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$293.00K 10-Q · filed 2025-08-06 | -$206.00K derived: sum of 3 quarters · filed 2025-08-06 | $217.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$358.00K 10-Q · filed 2025-05-15 | -$271.00K derived: sum of 2 quarters · filed 2025-05-15 | $152.00K derived: sum of 3 quarters · filed 2025-05-15 | -$170.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $510.00K derived: sum of 2 quarters · filed 2025-03-21 | $188.00K derived: sum of 3 quarters · filed 2025-03-21 | -$370.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $101.00K derived: sum of 2 quarters · filed 2024-11-08 | -$457.00K 10-Q · filed 2024-11-08 | $365.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$880.00K 10-Q · filed 2024-08-13 | -$58.00K derived: sum of 3 quarters · filed 2024-08-13 | -$227.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$558.00K 10-Q · filed 2024-05-10 | $264.00K derived: sum of 2 quarters · filed 2024-05-10 | $95.00K derived: sum of 3 quarters · filed 2024-05-10 | -$373.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $653.00K derived: sum of 2 quarters · filed 2024-03-28 | $185.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.23M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$637.00K derived: sum of 2 quarters · filed 2023-11-09 | $409.00K 10-Q · filed 2023-11-09 | $467.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$468.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $578.00K 10-Q · filed 2023-08-10 | $636.00K derived: sum of 3 quarters · filed 2023-08-10 | -$1.12M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.05M 10-Q · filed 2023-05-12 | $1.10M derived: sum of 2 quarters · filed 2023-05-12 | -$653.00K derived: sum of 3 quarters · filed 2023-05-12 | $1.03M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.70M derived: sum of 2 quarters · filed 2023-03-30 | -$20.00K derived: sum of 3 quarters · filed 2023-03-30 | -$17.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$78.00K derived: sum of 2 quarters · filed 2022-11-10 | -$75.00K 10-Q · filed 2022-11-10 | -$1.21M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.68M 10-Q · filed 2022-08-10 | $549.00K derived: sum of 3 quarters · filed 2022-08-10 | $1.41M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-12 | -$1.13M derived: sum of 2 quarters · filed 2022-05-12 | -$266.00K derived: sum of 3 quarters · filed 2022-05-12 | $87.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$269.00K derived: sum of 2 quarters · filed 2022-03-29 | $84.00K derived: sum of 3 quarters · filed 2022-03-29 | -$7.12M 10-K · filed 2022-03-29 |
| 2020-09-30 | $864.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.22M derived: sum of 2 quarters · filed 2021-11-10 | -$5.98M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$6.85M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$7.20M 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $7.20M 10-K · filed 2021-03-23 | |||
| 2018-09-30 | -$1.00K 10-Q · filed 2018-11-14 | |||
| 2018-03-31 | $153.00K 10-Q · filed 2019-05-15 | |||
| 2017-09-30 | $305.00K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |